In the intestinal pathway, KRAS and GNAS alterations drive the initiation, and then the IPMN progresses under the influence of CDX2 and RNF43 mutations via the GNAS-driven pathway to invasive colloid carcinoma. This evidence concerns the gene KRAS and pancreatic intraductal papillary-mucinous neoplasm.